WashingtonLifeScience.com

WaBio.com is now WashingtonLifeScience.com

WashingtonLifeScience.com (formerly known as WaBio.com) has been renamed to better reflect the broad diversity of the rapidly growing biotechnology, medical device, nanotechnology, pharmaceutical and related industry in the state of Washington.

More importantly, WashingtonLifeScience.com is now part of a specialized national network of state- and province-based biotechnology, medical device, and life science sites that includes more than 5,000 biotechnology, medical device, pharmaceutical companies, non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.

WashingtonLifeScience.com clients can now cost effectively advertise their job openings, events, facility availability and other services at the state level, Pacific Northwest level or nationwide for the same low rate.

More...

Destination Washington

Are you considering a move to Washington? Relocating your business to Washington? Starting a company? Or just interested in Washington?

This section will answer many of your questions regarding the life science industry in Washington, the state's economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history, industry resources, and more.

More...

Local News...

Free News Release Posting & Archiving Service

AstraZeneca granted temporary restraining order in PULMICORT RESPULES patent litigation On 19 November 2008, AstraZeneca was granted a Temporary Restraining Order (TRO) by the United States District Court for the District of New Jersey, halting sales of Teva's budesonide inhalation suspension product, a generic version of AstraZeneca's PULMICORT RESPULES treatment.
AstraZeneca November 20, 2008
AstraZeneca to realign supply chain to improve productivity and move closer to customers AstraZeneca has announced proposed changes to its global manufacturing and supply chain operations as part of its ongoing programme to improve efficiency across the business.
AstraZeneca November 20, 2008
Amgen, Takeda and Millennium provide update on Phase 3 trial of motesanib Amgen and Millennium announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended.
Amgen November 19, 2008
AstraZeneca enters agreement for authorized generic Pulmicort Respules AstraZeneca announced that it has entered into a supply and distribution agreement with Par Pharmaceutical to distribute an authorized generic version of budesonide inhalation suspension in the United States in response to the launch 'at risk' of a generic version of this product by Teva.
AstraZeneca November 19, 2008
FDA opens 1st office in China U.S. officials are launching a new strategy to improve the safety of the vast range of foods and other products imported from China and other countries to the United States. The Food and Drug Administration is opening its first office outside the United States in Beijing.
Austin American-Statesman (Texas) November 19, 2008 Craig Simons

More... | Submit News Release | National News

New Job Postings...

The Recruiter’s Studio: People, Careers, Conversations

Staff Scientist, Functional Cloning Novo Nordisk Inc. (WA)
Principal Staff Scientist Novo Nordisk Inc. (WA)
Senior Research Associate, Proteomics Novo Nordisk Inc. (WA)
Director, Cellular Immunology Novo Nordisk Inc. (WA)
Bioinformatics Scientist Institute for Systems Biology (WA)

More... | Job Advertising...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

890 Embarcadero Road Property -- West Sacramento, CA
Epigenomics Lab/Office Space -- Seattle, WA
Life Sciences Incubator -- Seattle, WA
University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

Free Event Posting Service

11/20/2008: Contamination Control 101 in Pharmaceutical, Biotech, and Medical Device Clean rooms.
11/24/2008: Current GMP and GCP Compliance Trends
11/24/2008: Science on Tap: Paul Yager, Dept of Bioengineering, University of Washington
11/25/2008: Clinical Trials in CNS
11/25/2008: Oncology Clinical Experience Programme

More... | Submit Event | Event Advertising...

Learn About Washington's BioHistory

Why is there a biotechnology industry in Washington? Will the industry continue to grow in Washington? What do other states have? Each state has a unique story that explains why a given industry has developed in a specific region and not in others.

Through Washington BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industries in the state of Washington.

More...

BioEvolution Posters

More...

November is American Diabetes Month

Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million) of them don't know that they have the disease. Millions more are at risk of developing diabetes.

Diabetes is a costly disease associated with serious complications and premature death. It is a major cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury, kidney failure, and new blindness in adults.

More...